According to OPKO Health 's latest financial reports the company's total assets are $2.01 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $2.01 B | -7.18% |
2022-12-31 | $2.16 B | -9.69% |
2021-12-31 | $2.39 B | -2.97% |
2020-12-31 | $2.47 B | 7.09% |
2019-12-31 | $2.30 B | -5.79% |
2018-12-31 | $2.45 B | -5.36% |
2017-12-31 | $2.58 B | -6.39% |
2016-12-31 | $2.76 B | -1.16% |
2015-12-31 | $2.79 B | 120.81% |
2014-12-31 | $1.26 B | -8.9% |
2013-12-31 | $1.39 B | 380.11% |
2012-12-31 | $0.28 B | 26.29% |
2011-12-31 | $0.22 B | 194.8% |
2010-12-31 | $77.84 M | -10.96% |
2009-12-31 | $87.43 M | 301.72% |
2008-12-31 | $21.76 M | -45% |
2007-12-31 | $39.56 M | 34010.34% |
2006-12-31 | $0.11 M | -98.71% |
2005-12-31 | $9 M | -10.63% |
2004-12-31 | $10.07 M | -11.21% |
2003-12-31 | $11.34 M | -35.24% |
2002-12-31 | $17.51 M | -36.6% |
2001-12-31 | $27.62 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $171.96 B | 8,448.29% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $73.21 B | 3,539.41% | ๐บ๐ธ USA |
Regeneron Pharmaceuticals REGN | $34.36 B | 1,608.49% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $99.03 B | 4,822.75% | ๐บ๐ธ USA |
LabCorp LH | $16.53 B | 721.74% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | $3.82 B | 90.11% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $43.47 B | 2,061.31% | ๐ฎ๐ฑ Israel |
Ardelyx ARDX | $0.29 B | -85.21% | ๐บ๐ธ USA |